Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Bernard O Abong'o"'
Autor:
Nicole Achee, George Okello, Eric Ochomo, John E. Gimnig, Simon Kariuki, Achuyt Bhattarai, Wycliffe Odongo, Jackline Kosgei, Stephen Munga, Eunice A. Ouma, Bernard O. Abong'o, John P. Grieco, Kiambo Njagi, Aaron M. Samuels, Fang Liu
Publikováno v:
Trials. 23(1)
Background Spatial repellents are widely used for prevention of mosquito bites and evidence is building on their public health value, but their efficacy against malaria incidence has never been evaluated in Africa. To address this knowledge gap, a tr
Autor:
Aklilu Seyoum, Jennifer S. Armistead, Joseph Chabi, Hieronymo T Masendu, Etienne Fondjo, Fiacre R. Agossa, Michael Okia, Richard M. Oxborough, Yemane Ye-ebiyo Yihdego, Arthur Sovi, Kevin Opondo, Mohamed Bayoh, Roch K. Dabiré, Virgile Gnanguenon, Jean-Desire Rakotoson, Francis Wat’senga, Samdi Lazarus Musa, Bernard O. Abong'o, Gedeon Yohannes, Libasse Gadiaga, Sylvester Coleman, Kenyssony Varela, Ousmane Faye, Evelyne Alyko, Ibrahima Baber, Jenny S. Carlson, Dereje Dengela
Publikováno v:
Malaria Journal
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Background Following agricultural use and large-scale distribution of insecticide-treated nets (ITNs), malaria vector resistance to pyrethroids is widespread in sub-Saharan Africa. Interceptor® G2 is a new dual active ingredient (AI) ITN treated wit
Autor:
Titus K. Kwambai, Menno R. Smit, Penelope A. Phillips-Howard, Duolao Wang, John E. Gimnig, Feiko O. ter Kuile, Simon Kariuki, Eric Ochomo, David Waterhouse, Teun Bousema, Ghaith Aljayyoussi, Stephen A. Ward, Nabie Bayoh, Aaron M. Samuels, Meghna Desai, Bernard O. Abong'o
Publikováno v:
Clinical Infectious Diseases, 69, 1112-1119
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases, 69(7), 1112-1119. Oxford University Press
Smit, M R, Ochomo, E O, Aljayyoussi, G, Kwambai, T K, Abong'o, B O, Bousema, T, Waterhouse, D, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, Ward, S A & ter Kuile, F O 2019, ' Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial) ', Clinical Infectious Diseases, vol. 69, no. 7, pp. 1112-1119 . https://doi.org/10.1093/cid/ciy1063
Clinical Infectious Diseases, 69, 7, pp. 1112-1119
Clinical Infectious Diseases, 69(7), 1112-1119. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical infectious diseases, 69(7), 1112-1119. Oxford University Press
Smit, M R, Ochomo, E O, Aljayyoussi, G, Kwambai, T K, Abong'o, B O, Bousema, T, Waterhouse, D, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, Ward, S A & ter Kuile, F O 2019, ' Human Direct Skin Feeding Versus Membrane Feeding to Assess the Mosquitocidal Efficacy of High-Dose Ivermectin (IVERMAL Trial) ', Clinical Infectious Diseases, vol. 69, no. 7, pp. 1112-1119 . https://doi.org/10.1093/cid/ciy1063
Clinical Infectious Diseases, 69, 7, pp. 1112-1119
Clinical Infectious Diseases, 69(7), 1112-1119. Oxford University Press
Background Ivermectin is being considered for mass drug administration for malaria, due to its ability to kill mosquitoes feeding on recently treated individuals. In a recent trial, 3-day courses of 300 and 600 mcg/kg/day were shown to kill Anopheles
Publikováno v:
International Journal of TROPICAL DISEASE & Health. :1-12
Background: Deaf adolescent children face greater challenges in accessing information, particularly on sexual and reproductive health (SRH) than those with other forms of disability. Parents therefore represent the first source of information for suc
Autor:
Benjamin Oloo, Stephen Munga, Celestine Wekesa, Tobias Odongo, Daniel Wacira, Mercy Nduta, Kevin Opondo, Richard M. Oxborough, Diana Omoke, Bradley Longman, Eric Ochomo, Margaret Muchoki, John E. Gimnig, Bernard O. Abong'o, Martin J. Donnelly, Amos Webwile
Publikováno v:
Parasites & Vectors, Vol 14, Iss 1, Pp 1-15 (2021)
Parasites & Vectors
Parasites & Vectors
Introduction Longitudinal monitoring of outdoor-biting malaria vector populations is becoming increasingly important in understanding the dynamics of residual malaria transmission. However, the human landing catch (HLC), the gold standard for measuri
Autor:
Celestine Wekesa, Bradley Longman, John E. Gimnig, Margaret Muchoki, Mercy Nduta, Richard M. Oxborough, Bernard O. Abong'o, Charity Ngaruro, Martin J. Donnelly, Diana Omoke, Stephen Munga, Tobias Odongo, Daniel Wacira, Amos Webwile, Eric Ochomo, Benjamin Oloo
Introduction. Longitudinal monitoring of outdoor-biting malaria vector populations is becoming increasingly important in understanding the dynamics of residual malaria transmission. However, the human landing catch (HLC), the gold standard for measur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecb7a219fa9f84de36e59a42557e6a1e
https://doi.org/10.21203/rs.3.rs-154054/v1
https://doi.org/10.21203/rs.3.rs-154054/v1
Autor:
Diana Omoke, John E. Gimnig, Martin J. Donnelly, James Maas, Bradley Longman, Richard M. Oxborough, Eric Ochomo, Stephen Munga, Christen Fornadel, Margaret Muchoki, Robert T. Perry, Stephen J. Torr, Feiko O. ter Kuile, Bernard O. Abong'o, Kiambo Njagi, Aaron M. Samuels
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-14 (2020)
Scientific Reports
Scientific Reports
Indoor residual spraying (IRS) of insecticides is a major vector control strategy for malaria prevention. We evaluated the impact of a single round of IRS with the organophosphate, pirimiphos-methyl (Actellic 300CS), on entomological and parasitologi
Autor:
Feiko O. ter Kuile, Menno R. Smit, Titus K. Kwambai, David Waterhouse, Teun Bousema, Aaron M. Samuels, John E. Gimnig, Ghaith Aljayyoussi, Bernard O. Abong'o, Nabie Bayoh, Eric Ochomo, Stephen A. Ward, Meghna Desai, Simon Kariuki, Penelope A. Phillips-Howard, Duolao Wang
Publikováno v:
Clinical Pharmacology and Therapeutics, 105, 2, pp. 388-401
Clinical Pharmacology & Therapeutics, 105(2), 388-401. Wiley-Blackwell
Clinical pharmacology and therapeutics, 105(2), 388-401. Wiley-Blackwell
Smit, M R, Ochomo, E O, Waterhouse, D, Kwambai, T K, Abong'o, B O, Bousema, T, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, ter Kuile, F O, Ward, S A & Aljayyoussi, G 2019, ' Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL) ', Clinical Pharmacology & Therapeutics, vol. 105, no. 2, pp. 388-401 . https://doi.org/10.1002/cpt.1219
Clinical Pharmacology and Therapeutics, 105, 388-401
Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics, 105(2), 388-401. Wiley-Blackwell
Clinical pharmacology and therapeutics, 105(2), 388-401. Wiley-Blackwell
Smit, M R, Ochomo, E O, Waterhouse, D, Kwambai, T K, Abong'o, B O, Bousema, T, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, ter Kuile, F O, Ward, S A & Aljayyoussi, G 2019, ' Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL) ', Clinical Pharmacology & Therapeutics, vol. 105, no. 2, pp. 388-401 . https://doi.org/10.1002/cpt.1219
Clinical Pharmacology and Therapeutics, 105, 388-401
Clinical Pharmacology and Therapeutics
High‐dose ivermectin, co‐administered for 3 days with dihydroartemisinin‐piperaquine (DP), killed mosquitoes feeding on individuals for at least 28 days posttreatment in a recent trial (IVERMAL), whereas 7 days was predicted pretrial. The curre
Autor:
Simon Kariuki, Titus K. Kwambai, Tao Chen, Menno R. Smit, Hannah C Slater, Aaron M. Samuels, Teun Bousema, Feiko O. ter Kuile, Duolao Wang, Ghaith Aljayyoussi, John E. Gimnig, Bernard O. Abong'o, Meghna Desai, Steve A. Ward, David Waterhouse, Penelope A. Phillips-Howard, Nabie Bayoh, Eric Ochomo
Publikováno v:
Lancet Infectious Diseases, 18, 6, pp. 615-639
Parasite
Smit, M R, Ochomo, E O, Aljayyoussi, G, Kwambai, T K, Abong'o, B O, Chen, T, Bousema, T, Slater, H C, Waterhouse, D, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, Ward, S A & ter Kuile, F O 2018, ' Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL) : a randomised, double-blind, placebo-controlled trial ', The Lancet Infectious Diseases, vol. 18, no. 6, pp. 615-626 . https://doi.org/10.1016/S1473-3099(18)30163-4
The Lancet Infectious Diseases, 18(6), 615-626. Lancet Publishing Group
Lancet Infectious Diseases, 18, 615-639
Parasite
Smit, M R, Ochomo, E O, Aljayyoussi, G, Kwambai, T K, Abong'o, B O, Chen, T, Bousema, T, Slater, H C, Waterhouse, D, Bayoh, N M, Gimnig, J E, Samuels, A M, Desai, M R, Phillips-Howard, P A, Kariuki, S K, Wang, D, Ward, S A & ter Kuile, F O 2018, ' Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL) : a randomised, double-blind, placebo-controlled trial ', The Lancet Infectious Diseases, vol. 18, no. 6, pp. 615-626 . https://doi.org/10.1016/S1473-3099(18)30163-4
The Lancet Infectious Diseases, 18(6), 615-626. Lancet Publishing Group
Lancet Infectious Diseases, 18, 615-639
Background: Ivermectin is being considered for mass drug administration for malaria due to its ability to kill mosquitoes feeding on recently treated individuals. However, standard, single doses of 150–200 μg/kg used for onchocerciasis and lymphat
Autor:
Ibrahima Baber, Richard M. Oxborough, Virgile Gnanguenon, Gedeon Yohannes, Bernard O. Abong'o, Stephen M. Magesa, Dereje Dengela, Bradford Lucas, Christen Fornadel, Aklilu Seyoum, Abdoulaye Diop, Hieronymo T Masendu, Alphaxard Manjurano, Michael Okia, Sylvester Coleman, Lazarus Musa Samdi, Kenyssony Varela, Evelyne Alyko, Roch K. Dabiré, Ousmane Faye, Fiacre R. Agossa, Jean-Desire Rakotoson, Yemane Ye-ebiyo Yihdego, Francis Wat’senga, Arthur Sovi
Publikováno v:
Malaria Journal
Malaria Journal, Vol 18, Iss 1, Pp 1-11 (2019)
Malaria Journal, Vol 18, Iss 1, Pp 1-11 (2019)
Background In 2017, more than 5 million house structures were sprayed through the U.S. President’s Malaria Initiative, protecting more than 21 million people in sub-Saharan Africa. New IRS formulations, SumiShield™ 50WG and Fludora Fusion™ WP-S